Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity

References

• LanceJWThe control of muscle tone, reflexes, and movement: Robert Wartenberg lectureNeurology19813012130313137192811
   PubMed Web of Science ®Google Scholar
• AllisonRShentonLBamforthKKilbrideCRichardsDIncidence, time course and predictors of impairments relating to caring for the profoundly affected arm after stroke: a systematic reviewPhysiother Res Int Epub2015525
   PubMedGoogle Scholar
• UrbanPPWolfTUebeleMOccurrence and clinical predictors of spasticity after ischemic strokeStroke2010412016202020705930
   PubMed Web of Science ®Google Scholar
• BraininMNorrvingBSunnerhagenKSPoststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complicationsInt J Stroke20116424621205240
   PubMed Web of Science ®Google Scholar
• ChouRPetersonKHelfandMComparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic reviewJ Pain Symptom Manage20042814017515276195
   PubMed Web of Science ®Google Scholar
• StevensonVRehabilitation in practice: spasticity managementClin Rehabil20102429330420360150
   PubMed Web of Science ®Google Scholar
• FranciscoGEBoakeCImprovement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary studyArch Phys Med Rehabil2003841194119912917859
   PubMed Web of Science ®Google Scholar
• MeythalerJMGuin-RenfroeSBrunnerRCHadleyMNIntrathecal baclofen for spastic hypertonia from strokeStroke2001322099210911546903
   PubMed Web of Science ®Google Scholar
• EsquenaziANovakISheeanGSingerBWardAInternational consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments–introductionEur J Neurol2010171820633176
   PubMed Web of Science ®Google Scholar
• DemetriosMGorelikALouieJBrandCBaguleyIJKhanFOutcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with strokeJ Rehabil Med20144673073725073939
   PubMed Web of Science ®Google Scholar
• FranceschiniMIoccoMMolteniFSantamatoASmaniaNManagement of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectorsEur J Phys Rehabil Med20145052553224963604
   PubMed Web of Science ®Google Scholar
• ErbguthFJNaumannMHistorical aspects of botulinum toxin Justinus Kerner (1786–1862) and the “sausage poison”Neurology1999531850185010563638
   PubMed Web of Science ®Google Scholar
• GimenezDFGiménezJASerological Subtypes of Botulinal Neurotoxins. Botulinum and Tetanus NeurotoxinsNew YorkSpringer1993421431
   Google Scholar
• SimpsonLLThe origin, structure, and pharmacological activity of botulinum toxinPharmacol Rev1981331551886119708
   PubMed Web of Science ®Google Scholar
• SimpsonLLIdentification of the major steps in botulinum toxin actionAnnu Rev Pharmacol Toxicol20044416719314744243
   PubMed Web of Science ®Google Scholar
• AokiKGuyerBBotulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actionsEur J Neurol20018212911851731
   PubMed Web of Science ®Google Scholar
• FrevertJContent of botulinum neurotoxin in botox®/vistabel®, dysport®/azzalure®, and xeomin®/bocouture®Drugs R D201010677320698714
   PubMedGoogle Scholar
• GuptaBRDSugiyamaHRole of a protease in natural activation of Clostridium botulinum neurotoxinInfect Immun197265875904564288
   PubMed Web of Science ®Google Scholar
• BlasiJChapmanERLinkEBotulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25Nature19933651601638103915
   PubMed Web of Science ®Google Scholar
• SchiavoGGBenfenatiFPoulainBTetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevinNature19923598328351331807
   PubMed Web of Science ®Google Scholar
• de PaivaAMeunierFAMolgóJAokiKRDollyJOFunctional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminalsProc Natl Acad Sci U S A1999963200320510077661
   PubMed Web of Science ®Google Scholar
• SimpsonDGraciesJGrahamHAssessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyNeurology2008701691169818458229
   PubMed Web of Science ®Google Scholar
• HesseSReiterFKonradMJahnkeMTBotulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trialClin Rehabil1998123813889796928
   PubMed Web of Science ®Google Scholar
• McCroryPTurner-StokesLBaguleyIJBotulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomesJ Rehabil Med20094153654419543664
   PubMed Web of Science ®Google Scholar
• ShawLCPriceCIvan WijckFMBotulinum toxin for the upper limb after stroke (BoTULS) trial effect on impairment, activity limitation, and painStroke2011421371137921415398
   PubMed Web of Science ®Google Scholar
• SmithSEllisEWhiteSMooreAA double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injuryClin Rehabil20001451310688339
   PubMed Web of Science ®Google Scholar
• RosalesRLKongKHGohKJBotulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke a randomized controlled trialNeurorehabil Neural Repair20122681282122371239
   PubMed Web of Science ®Google Scholar
• BrashearAGordonMFElovicEIntramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a strokeN Engl J Med200234739540012167681
   PubMed Web of Science ®Google Scholar
• SuputtitadaASuwanwelaNThe lowest effective dose of botulinum A toxin in adult patients with upper limb spasticityDisabil Rehabil20052717618415824048
   PubMed Web of Science ®Google Scholar
• Turner-StokesLBaguleyIJDe GraaffSGoal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trialJ Rehabil Med201042818920111849
   PubMed Web of Science ®Google Scholar
• BakheitAPittockSMooreAA randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with strokeEur J Neurol2001855956511784339
   PubMed Web of Science ®Google Scholar
• BakheitAThilmannAWardAA randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after strokeStroke2000312402240611022071
   PubMed Web of Science ®Google Scholar
• BhaktaBBCozensJAChamberlainMABamfordJMImpact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trialJ Neurol Neurosurg Psychiatry20006921722110896696
   PubMed Web of Science ®Google Scholar
• GraciesJ-MBrashearAJechRSafety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trialLancet Neurol201514992100126318836
   PubMed Web of Science ®Google Scholar
• LamKLauKKSoKKCan botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled studyJ Am Med Dir Assoc20121347748422521630
   PubMed Web of Science ®Google Scholar
• SimpsonDMGraciesJ-MYablonSABarbanoRBrashearABotulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled studyJ Neurol Neurosurg Psychiatry20098038038518977811
   PubMed Web of Science ®Google Scholar
• JahangirATanHNorlinahMIntramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after strokeMed J Malaysia20076231918551937
   PubMedGoogle Scholar
• SimpsonDAlexanderDO’brienCBotulinum toxin type A in the treatment of upper extremity spasticity A randomized, double-blind, placebo-controlled trialNeurology199646130613068628472
   PubMed Web of Science ®Google Scholar
• RichardsonDSheeanGWerringDEvaluating the role of botulinum toxin in the management of focal hypertonia in adultsJ Neurol Neurosurg Psychiatry20006949950610990511
   PubMed Web of Science ®Google Scholar
• ChildersMKBrashearAJozefczykPDose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a strokeArch Phys Med Rehabil2004851063106915241751
   PubMed Web of Science ®Google Scholar
• MarciniakCMHarveyRLGagnonCMDoes botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trialAm J Phys Med Rehabil2012911007101923064478
   PubMed Web of Science ®Google Scholar
• KajiROsakoYSuyamaKMaedaTUechiYIwasakiMBotulinum toxin type A in post-stroke upper limb spasticityCurr Med Res Opin2010261983199220569068
   PubMed Web of Science ®Google Scholar
• WardABWisselJBorgJFunctional goal achievement in post-stroke spasticity patients: the BOTOX® economic spasticity trial (BEST)J Rehabil Med20144650451324715249
   PubMed Web of Science ®Google Scholar
• KanovskýPSlawekJDenesZEfficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticityClin Neuropharmacol20093225926519644361
   PubMed Web of Science ®Google Scholar
• KaňovskýPSlawekJDenesZEfficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticityJ Rehabil Med20114348649221533328
   PubMed Web of Science ®Google Scholar
• ElovicEPMuninMCKaňovskýPHanschmannAHiersemenzelRMarciniakCRandomized, placebo-controlled trial of incobotulinumtoxinA for upper-limb post-stroke spasticityMuscle Nerve Epub2015722
   PubMed Web of Science ®Google Scholar
• BrashearAMcAfeeALKuhnERFyffeJBotulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trialArch Phys Med Rehabil20048570570915129392
   PubMed Web of Science ®Google Scholar
• GraciesJ-MBayleNGoldbergSSimpsonDMBotulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary studyArch Phys Med Rehabil2014951303131124709034
   PubMed Web of Science ®Google Scholar
• DunneJWGraciesJ-MHayesMZemanBSingerBJGroupMSA prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after strokeClin Rehabil20122678779722308557
   PubMed Web of Science ®Google Scholar
• KajiROsakoYSuyamaKMaedaTUechiYIwasakiMBotulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trialJ Neurol20102571330133720358216
   PubMed Web of Science ®Google Scholar
• PittockSMooreAHardimanOA double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport®) in the treatment of spastic equinovarus deformity after strokeCerebrovasc Dis20031528930012686794
   PubMed Web of Science ®Google Scholar
• MohammadiBAbdoulrahmani BalouchSDenglerRKolleweKLong-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patientsNeurol Res20103230931319726016
   PubMed Web of Science ®Google Scholar
• BurbaudPWiartLDubosJA randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patientsJ Neurol Neurosurg Psychiatry1996612652698795597
   PubMed Web of Science ®Google Scholar
• WisselJWardABErztgaardPEuropean consensus table on the use of botulinum toxin type A in adult spasticityJ Rehabil Med200941132519197564
   PubMed Web of Science ®Google Scholar
• BaricichAGranaECardaSSantamatoACisariCInvernizziMHigh doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysisJ Neural Transm (Vienna)201512291283128725724294
   PubMed Web of Science ®Google Scholar
• SantamatoAMicelloMFRanieriMEmployment of higher doses of botulinum toxin type A to reduce spasticity after strokeJ Neurol Sci20153501625684341
   PubMed Web of Science ®Google Scholar
• YablonSABrinMFVanDenburghAMDose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysisMov Disord20112620921520960474
   PubMed Web of Science ®Google Scholar
• NalysnykLPapapetropoulosSRotellaPSimeoneJCAlterKEEsquenaziAOnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature reviewBMC Neurol20131311824011236
   PubMed Web of Science ®Google Scholar
• SimpsonDPatelAAlfaroAUsing a Delphi panel to identify a treatment paradigm for injecting botulinum toxin to treat common postures in post-stroke upper limb spasticity (P5. 167)Neurology201584P516725480912
   PubMedGoogle Scholar
• GraciesJ-MLugassyMWeiszDJVecchioMFlanaganSSimpsonDMBotulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled studyArch Phys Med Rehabil2009909.e16.e19154823
   PubMed Web of Science ®Google Scholar
• AmiraliAMuLGraciesJ-MSimpsonDMAnatomical localization of motor endplate bands in the human biceps brachiiJ Clin Neuromuscul Dis2007930631218090684
   PubMedGoogle Scholar
• MolloyFShillHKaelin-LangAKarpBAccuracy of muscle localization without EMG: implications for treatment of limb dystoniaNeurology20025880580711889247
   PubMed Web of Science ®Google Scholar
• PicelliALobbaDMidiriABotulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniquesClin Rehabil20142823224223945164
   PubMed Web of Science ®Google Scholar
• HenzelMKMuninMCNiyonkuruCSkidmoreERWeberDJZafonteRDComparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injectionsPM R2010264264620659720
   PubMedGoogle Scholar
• SantamatoAMicelloMFPanzaFCan botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniquesJ Neurol Sci2014347394325263601
   PubMed Web of Science ®Google Scholar
• YiannakopoulouESerious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxinPharmacology201595656925613637
   PubMed Web of Science ®Google Scholar
• GordonMBrashearAElovicERepeated dosing of botulinum toxin type A for upper limb spasticity following strokeNeurology2004631971197315557529
   PubMed Web of Science ®Google Scholar
• NaumannMCarruthersACarruthersJMeta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indicationsMov Disord2010252211221820737546
   PubMed Web of Science ®Google Scholar
• DresslerDMünchauABhatiaKPQuinnNPBigalkeHAntibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses?Eur Neurol20014711812111844901
   PubMed Web of Science ®Google Scholar
• BarnesMBestDKiddLThe use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A-initial experiencesEur J Neurol20051294795516324088
   PubMed Web of Science ®Google Scholar
• BensmailDHanschmannAWisselJSatisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians)J Med Econ20141761862524841450
   PubMedGoogle Scholar
• ShawLRodgersHPriceCBoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type AHealth Technol Assess201014261113iiiiv20515600
   PubMed Web of Science ®Google Scholar
• RozeSKurthHHuntBValentineWMartyREvaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countriesMed Devices (Auckl)201259723204875
   PubMedGoogle Scholar
• RosalesRLKanovskyPFernandezHHWhat’s the “catch” in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applicationsParkinsonism Relat Disord201117S3S1021999894
   PubMed Web of Science ®Google Scholar
• GhasemiMAnsariMBasiriKShaigannejadVThe effects of intra-dermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathyJ Res Med Sci20141910624778662
   PubMed Web of Science ®Google Scholar
• YuanRSheuJYuJBotulinum toxin for diabetic neuropathic pain A randomized double-blind crossover trialNeurology2009721473147819246421
   PubMed Web of Science ®Google Scholar
• TaylorMSilvaSCottrellCBotulinum toxin type-A (BOTOX®) in the treatment of occipital neuralgia: a pilot studyHeadache2008481476148119076646
   PubMed Web of Science ®Google Scholar
• WuC-JLianY-JZhengY-KBotulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trialCephalalgia20123244345022492424
   PubMed Web of Science ®Google Scholar
• CarrollIClarkJDMackeySSympathetic block with botulinum toxin to treat complex regional pain syndromeAnn Neurol20096534835119334078
   PubMed Web of Science ®Google Scholar